Celularity is a biotechnology company that develops cell and tissue regenerative therapies for cancer, chronic and degenerative diseases.
Business Model:
Revenue: $24.5M
Employees: 201-500
Address: 170 Park Ave
City: Florham Park
State: NJ
Zip: 07932
Country: US
Celularity is a biotechnology company that develops cell and tissue regenerative therapies for cancer, chronic and degenerative diseases.
Contact Phone:
+19087682170
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/19/2021
IPO Valuation:
$2B
Ticker Symbol:
CELU
Amount Raised:
$372M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2017 | Series A | 2 | $40M |
Castor Ventures Alumni Ventures Castor Ventures |
5/2018 | Equity | $77.7M | 7/2021 | Post-IPO Equity | 3 | $80M |
Dragasac Limited Sorrento Therapeutics Starr Insurance Companies Dragasac Limited Sorrento Therapeutics Starr Insurance Companies |
2/2018 | Series A | 8 | $250M |
Human Longevity Section 32 Celgene Heritage Group Tony Robbins Bill Maris United Therapeutics Celgene Sorrento Therapeutics Section 32 Celgene Heritage Group Tony Robbins Bill Maris United Therapeutics Human Longevity Celgene |
7/2021 | IPO SPAC | $138M | 5/2022 | Private Placement | $30M | 8/2017 | Equity | $40M |
Sorrento Therapeutics |
5/2022 | Post-IPO Equity | $30M |
---|
Announced Date | Name | Price |
---|---|---|
8/2018 | Caricord |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|